No abstract available.

OBJECTIVE: To evaluate the perinatal prognosis of fetuses with a single umbilical artery. METHODS: From 1992 to 1998, nineteen cases with single umbilical artery(SUA) was observed in 8,704 deliveries at Chonnam University Hospital. RESULTS: Out of nineteen fetuses, thirteen fetuses with single umbilical artery were detected by antenatal ultrasonographic examination and six fetuses were detected after birth. The male to female ratio was 0.9: 1. Congenital malformations were observed in 8 babies(42.1%) and included leg deformity, esophageal atresia, imperforated anus, ventriculomegaly, meningocele, hydronephrosis, ventricular septal defect, joint contracture, cleft lip and palate, toe anomaly, imperforated anus, kyphosis, no urethra and testis, clubfoot, patent ductus arteriosus and rnild mitral regurgitation. Among 10 cases of karyotyping analysis three cases were diagnosed as trisomy 18. Fourteen fetuses(77.8%) showed growth restriction at delivery. Antenatal obstetric complications were hydramnios(n = 3), oligohydramnios(n =2), and severe preeclampsia(n = 3). CONCLUSION: Careful ultrasonographic evaluation for the identification of a SUA is necessary because of its frequent association with congenital anomaly, growth restriction and cytogenetic abnormality.
Anal Canal ; Chromosome Aberrations ; Cleft Lip ; Clubfoot ; Congenital Abnormalities ; Contracture ; Ductus Arteriosus, Patent ; Esophageal Atresia ; Female ; Fetus ; Heart Septal Defects, Ventricular ; Humans ; Hydronephrosis ; Jeollanam-do ; Joints ; Karyotyping ; Kyphosis ; Leg ; Male ; Meningocele ; Mitral Valve Insufficiency ; Palate ; Parturition ; Prognosis* ; Single Umbilical Artery* ; Testis ; Toes ; Trisomy ; Urethra

No abstract available.
Gram-Positive Bacterial Infections* ; Teicoplanin*

No abstract available.
Epidermal Cyst*

No abstract available.
Prevalence* ; Seoul*

No abstract available.
Prevalence* ; Seoul*

No abstract available.
Graves Disease* ; Insulin*

PURPOSE: Asthma is an important worldwide pediatric public health problem and rapidly increasing prevalence has been reported. Environmental tobacco smoke (ETS) is known to be an important aggravation factor of asthma. The aim of this study was to determine whether ETS exposure is associated with exacerbations of asthma, and therefore to define the possibility of improving illness by cessation of smoking. METHODS: One hundred one (101) asthmatic children who visited and followed up at Korea university hospital pediatric allergy clinic were enrolled. Their chart was reviewed retrospectively and their family members were also interviewed. RESULTS: Sixty nine patients were exposed to ETS and thirty two patients were not exposed. Among exposed group (n=69), fourteen patients were no longer exposed due to cessation of smoking. The difference in the number of hospital admissions between exposed group and non-exposed was statistically significant (P=0.002). But the difference in the number of emergency room visits and PFT value (FEV1, PEFR, FEF25-75%) between the two groups was statistically insignificant. Statistical relationship between the duration of ETS and number of hospital admissions was significant (Pearson Correlation Coefficient=0.243, P=0.015). Comparing current smoking group and smoking cessation group, differences in out-patient clinic follow up period, number of hospital admissions, and number of emergency room visits between the two groups were statistically insignificant. CONCLUSION: We found that ETS exposure is associated with exacerbations of asthma. Possibility of improving illness by reduction of ETS exposure indicates the significance of education for cessation of smoking.
Asthma* ; Child ; Education ; Emergency Service, Hospital ; Follow-Up Studies ; Humans ; Hypersensitivity ; Korea ; Outpatients ; Peak Expiratory Flow Rate ; Prevalence ; Public Health ; Retrospective Studies ; Smoke* ; Smoking ; Smoking Cessation ; Tobacco*

There had been a continuous evolution of lymphoma classification and recently a Revised European-American Lymphoma Classification was proposed by the International Lymphoma Study Group. This new classification often requires information on immunophenotypic and molecular biologic markers in addition to the usual histologic findings. Recent advances in the production of commercially available monoclonal antibodies reactive on formalin-fixed paraffin-embedded tissues provide us a great help to classify the non-Hodgkin's lymphoma. We have analyzed 31 low grade B-cell lymphomas by the schemes proposed by the International Lymphoma Study Group using antibodies to CD3, CD5, CD20, CD23, CD43, cyclin D1, and bcl-2 protein, and have analyzed the immunophenotypic features. Among 31 low grade B-cell lymphomas, 8 small lymphocytic lymphomas, 5 mantle cell lymphomas, 7 follicle center lymphomas (2 grade I, 3 grade II, and 2 grade III), and 11 marginal zone B-cell lymphomas (all of which were extranodal) were identified. Among 8 small lymphocytic lymphomas, 5 cases were positive for CD5; 6 cases were positive for CD23; 7 cases were positive for CD43; all 8 cases were negative for cyclin D1; and 7 cases were positive for bcl-2. Among 5 mantle cell lymphomas, 4 cases were positive for CD5 and CD43; all five cases were negative for CD23; 4 cases were positive for cyclin D1 and bcl-2. All 7 follicle center lymphomas were negative for CD5, CD43 and cyclin D1 and 2 cases were positive for CD23; and 6 cases were positive for bcl-2. All marginal zone B-cell lymphomas were negative for CD5, CD23 and cyclin D1; 3 cases were positive for CD43 and 9 cases were positive for bcl-2. Diagnostic utility for CD5 antigen detection on paraffin embedded tissue has a limitation due to weak antigen expression in tumor cells of B-cell lymphomas; however, still be useful in differentiating small lymphocytic lymphoma and mantle cell lymphoma from other B-cell lymphomas when applied in conjunction with CD43. CD23, CD43, and cyclin D1 appear to be of great help in differentiating subgroups of low grade B-cell lymphomas. Bcl-2, as known, is found to be useful to rule out reactive follicular hyperplasia.
Antibodies ; Antibodies, Monoclonal ; Antigens, CD5 ; B-Lymphocytes* ; Biomarkers ; Classification ; Cyclin D1 ; Hyperplasia ; Immunohistochemistry* ; Leukemia, Lymphocytic, Chronic, B-Cell ; Lymphoma ; Lymphoma, B-Cell* ; Lymphoma, B-Cell, Marginal Zone ; Lymphoma, Mantle-Cell ; Lymphoma, Non-Hodgkin ; Paraffin*

No abstract available.
Psoriasis